Anxiety Disorder Clinical Trial
Official title:
Double Blind, Randomized Study, Controlled by Valeriana Officinalis, of Association of Passiflora Incarnata L; Crataegus Oxyacantha L and Salix Alba L. on Patients With Mild and Moderate Anxiety
Phase III, multicentric, double blind, randomized study, controlled by Valeriana officinalis
for evaluating the efficacy of association of Passiflora incarnata L; Crataegus Oxyacantha L
and Salix alba L. on mild and moderate anxiety. The treatment period will last 6 weeks and
be followed by a post treatment visit.
Hamilton anxiety scale will be used to assess anxiety.
Passiflora incarnata L; Crataegus Oxyacantha L are plant-derived treatment widely used to
treat anxiety disorders. This study will compare the association of Passiflora incarnata L;
Crataegus Oxyacantha L and Salix alba L for the treatment of mild and moderate anxiety. 150
participants will be randomly assigned to receive the association of Passiflora incarnata L;
Crataegus Oxyacantha L and Salix alba L. or Valeriana officinalis for 6 weeks. A post
treatment visit will be done 2 weeks for safety evaluation.
Primary outcome: Hamilton anxiety (HAM-A) scale Secondary outcome: Insomnia quality index,
Global clinical impression and patients global evaluation scales.
Side effects will be monitorized throughout the study.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06038721 -
Unified Protocol: Community Connections
|
N/A | |
| Not yet recruiting |
NCT03224845 -
Courageous Parents, Courageous Children
|
N/A | |
| Completed |
NCT02096783 -
Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Cancer
|
N/A | |
| Completed |
NCT02145429 -
Preventing Depression in Late Life: A Model for Low and Middle Income Countries
|
N/A | |
| Terminated |
NCT00896467 -
Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial Therapy
|
N/A | |
| Completed |
NCT00252343 -
Efficacy and Safety of SR58611A in Patients With a Generalized Anxiety Disorder
|
Phase 3 | |
| Not yet recruiting |
NCT05867823 -
OcupApp: Occupational Self-analysis Intervention Through an Mobile Application
|
N/A | |
| Recruiting |
NCT04562324 -
Efficacy of Electroencephalography (EEG) Neurofeedback (NF) for the Treatment of Anxiety Disorder
|
N/A | |
| Recruiting |
NCT05989451 -
Adaptation of Individual Dialectical Behavior Therapy Intervention for Transdiagnostic Treatment of Emotional Disorders
|
N/A | |
| Not yet recruiting |
NCT05488418 -
Clinical Study of Biomarkers of Stress Resilience: Role of ELK1 and GPR56
|
N/A | |
| Not yet recruiting |
NCT03608449 -
Doing More With Less": Optimizing Psychotherapeutic Services in the Mental Health System
|
N/A | |
| Completed |
NCT03400397 -
An Effectiveness Study of the Cool Kids Programme
|
N/A | |
| Completed |
NCT00025844 -
Fear Conditioning Using Computer-Generated Virtual Reality
|
N/A | |
| Completed |
NCT02579928 -
Ketamine Infusion for Adolescent Depression and Anxiety
|
Phase 4 | |
| Completed |
NCT02270073 -
The Process Outcome Mindfulness Effects in Trainees (PrOMET)-Study
|
N/A | |
| Terminated |
NCT03764644 -
Web-based Attention Bias Modification Treatment for Childhood Anxiety Disorders
|
N/A | |
| Completed |
NCT01425619 -
The Effect of Medical Clowns and Topical Anesthetic Cream on Pain and Anxiety in Children Undergoing Allergy Skin Tests
|
N/A | |
| Completed |
NCT01721824 -
The Effect of IPS-MA- A Modified Early Supported Employment Intervention for Individuals With Mood or Anxiety Disorders
|
N/A | |
| Completed |
NCT01227980 -
Corticotropin-Releasing Hormone Receptor 1 (CRH1) Antagonism in Anxious Alcoholics^
|
Phase 2 | |
| Completed |
NCT01730625 -
Augmenting Effects of ABMT on CBT in Anxious Children: A Randomized Clinical Trial
|
N/A |